We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.
- Authors
Giskeødegård, Guro F; Hansen, Ailin Falkmo; Bertilsson, Helena; Gonzalez, Susana Villa; Kristiansen, Kåre Andre; Bruheim, Per; Mjøs, Svein A; Angelsen, Anders; Bathen, Tone Frost; Tessem, May-Britt; Giskeødegård, Guro F; Kristiansen, Kåre Andre; Mjøs, Svein A
- Abstract
<bold>Background: </bold>An individualised risk-stratified screening for prostate cancer (PCa) would select the patients who will benefit from further investigations as well as therapy. Current detection methods suffer from low sensitivity and specificity, especially for separating PCa from benign prostatic conditions. We have investigated the use of metabolomics analyses of blood samples for separating PCa patients and controls with benign prostatic hyperplasia (BPH).<bold>Methods: </bold>Blood plasma and serum samples from 29 PCa patient and 21 controls with BPH were analysed by metabolomics analysis using magnetic resonance spectroscopy, mass spectrometry and gas chromatography. Differences in blood metabolic patterns were examined by multivariate and univariate statistics.<bold>Results: </bold>By combining results from different methodological platforms, PCa patients and controls were separated with a sensitivity and specificity of 81.5% and 75.2%, respectively.<bold>Conclusions: </bold>The combined analysis of serum and plasma samples by different metabolomics measurement techniques gave successful discrimination of PCa and controls, and provided metabolic markers and insight into the processes characteristic of PCa. Our results suggest changes in fatty acid (acylcarnitines), choline (glycerophospholipids) and amino acid metabolism (arginine) as markers for PCa compared with BPH.
- Publication
British Journal of Cancer, 2015, Vol 113, Issue 12, p1712
- ISSN
0007-0920
- Publication type
journal article
- DOI
10.1038/bjc.2015.411